ISC Intelligence in Science has been a partner in a number of successful EU-funded projects. Below find a selection of projects which were funded under the Framework Programmes:
IMPACT Europe is a project funded by the European Union’s Seventh Framework Programme aiming to fill the gap in knowledge and understanding of ‘what works’ in tackling violent radicalisation. Running from January 2014 to June 2017, this work will be the result of extensive, multidisciplinary, and end-user focused research and development by some of the most renowned research institutes in Europe and beyond.
The project will answer three questions to fill gaps in our knowledge that are currently limiting the effectiveness of counter-violent-radicalisation work:
1. How effective are various programmes at tackling violent radicalisation?
2. What is best practice in tackling violent radicalisation?
3. How does this inform our knowledge and understanding of violent radicalisation?
The outcome of IMPACT Europe will improve and empower counter-violent-radicalisation policies and interventions across Europe.
The project website is at http://impacteurope.eu
IMPACT Europe will develop an evaluation toolkit to help professionals in the public and voluntary sectors design and implement an evaluation of their programmes tackling violent radicalisation, whether policies or interventions. The toolkit will also help professionals go beyond the evaluation of a single project by integrating best practice into the design and implementation of future programmes.
This evaluation toolkit will be composed of four elements:
1. A standardised methodology, to provide professionals with a tool to conduct robust evaluations;
2. An evaluation results database, to allow professionals to analyse these results over time, identify best practice and develop a more informed understanding of violent radicalisation;
3. A training course (including a train-the-trainer component), to build professionals’ capacity to design, carry out and learn from appropriate evaluations;
4. A training manual, to provide easy reference for professionals applying the toolkit.
The project runs from January 2014 to June 2017.
IMPACT Europe Consortium consists of 12 partners drawn from across Europe and beyond, specialising in academic and applied research, evaluation, community engagement, policing, commercial software and communications. Further information on each partner and their role in the project is provided at the links below.
Two additional partners in the form of other end-user organisations may be recruited during the project.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 312235
PAERIP was a project funded under FP7 (Theme INFRA-2010-3.2).
The project created a dedicated initiative to promote research infrastructure partnerships between Europe and Africa. There is currently significant political attention on promoting science and technology partnerships between the European Union and Africa. The Joint Africa-European Union (EU) Strategy, adopted by Heads of Government at the December 2007 Lisbon Summit, notably includes a dedicated Science, Information Society and Space initiative. Several collaborative efforts are currently being implemented under this Partnership, with the support of the African Union Commission, the European Commission and African and European Union Member States. None of these initiatives are, however, specifically addressing research infrastructures except the targeted intervention to build high-speed research networking capacities in selected African countries under the AfricaConnect project. The “Promoting African European Research Infrastructure Partnerships” (PAERIP) project was specifically focused on addressing this void notably by undertaking a series of relevant studies, which informed the organisation of policy dialogue and cooperation promotion events.
ITFoM was one of the 6 Future and Emerging Technologies Flagship Pilots which were funded for a 12-month period since May 20111. The initiatives were coordinated between national and EU programmes and presented global dimensions to foster European leadership and excellence in froniert research.
Data-rich, individualised medicine poses unprecedented challenges for IT, in hardware, storage and communication. IT Future of Medicine proposed a data-driven, individualised medicine of the future, based on molecular/physiological/anatomical data from individual patients. The aim was to make general models of human pathways, tissues, diseases and ultimately of the human as a whole. Individualised versions of the models, produced for each patient, will then be used to identify personalised prevention/therapy schedules and side effects of drugs.
To develop this IT driven, data rich, individualised medicine of the future, this first-phase flagship project prepared for the amalgamation of 5 major areas: medicine, from sample and diagnosis provision to clinical practice and patient consent, analytical techniques, covering functional genomics and imaging technology analyses on a routine basis, IT developments required to address the computational challenges, and integration, developing interfaces, modelling and machine learning tools required to integrate the data generated through the different analysis streams, and to inform relevant health providers. A coordination work package addressed the administrative, educational, funding and translational components of the work.
This was the first time the huge IT implications of worldwide individualized patient care were addressed and combined with up-to-date genomics and requirements from the medical field. The project outcomes were supposed to enable the calculation of health, disease, therapy and its effects for individual patients. The intention was to revolutionize our health care with enormous (i) benefits for health (prevention, diagnosis and therapy), (ii) reduction in health care cost by individualising combinations of a limited number of drugs, and (iii) new commercial opportunities in the IT, analytic and health care sectors.